International Impact of COVID-19 on the Diagnosis of Heart Disease.
International Impact of COVID-19 on the Diagnosis of Heart Disease.
复制标题
DOI：
10.1016/j.jacc.2020.10.054
复制
发表时间：
2021-01-19
影响因子：
24
通讯作者：
INCAPS COVID Investigators Group
中科院分区：
文献类型：
--
作者：
Einstein AJ;Shaw LJ;Hirschfeld C;Williams MC;Villines TC;Better N;Vitola JV;Cerci R;Dorbala S;Raggi P;Choi AD;Lu B;Sinitsyn V;Sergienko V;Kudo T;Nørgaard BL;Maurovich-Horvat P;Campisi R;Milan E;Louw L;Allam AH;Bhatia M;Malkovskiy E;Goebel B;Cohen Y;Randazzo M;Narula J;Pascual TNB;Pynda Y;Dondi M;Paez D;the;INCAPS COVID Investigators Group
2019冠状病毒病（COVID-19）大流行对非传染性疾病的诊断和治疗产生了不利影响。它对心血管疾病诊断护理服务的影响尚未量化，心血管疾病仍然是世界范围内的主要死亡原因。该研究旨在评估COVID-19对全球心血管诊断手术量和安全实践的影响。国际原子能机构进行了一项全球调查，评估COVID-19导致的心血管手术量和安全实践的变化。从参与研究中心获得了2020年3月和4月的无创和有创心脏测试量，并与2019年3月的测试量进行了比较。确定了个人防护设备的可用性和与流行病有关的检测做法的变化。调查来自108个国家的909个进行心脏诊断程序的住院和门诊中心。从2019年3月到2020年3月，手术量减少了42%，从2019年3月到2020年4月，手术量减少了64%。经胸超声心动图减少了59%，经食管超声心动图减少了76%，负荷试验减少了78%，这在负荷模式之间有所不同。冠状动脉造影术（侵入性或计算机断层扫描）降低了55%（每种手术p < 0.001）。在多变量回归分析中，国内生产总值较低国家的中心手术减少幅度显著更大。位于低收入和中低收入国家与心脏手术额外减少22%以及个人防护设备和远程医疗的可用性减少有关。COVID-19与地球仪心血管诊断测试的显著和突然减少有关，特别是影响了世界上经济困难的国家。需要进一步研究心血管结局和COVID-19相关的护理变化。
The coronavirus disease 2019 (COVID-19) pandemic has adversely affected diagnosis and treatment of noncommunicable diseases. Its effects on delivery of diagnostic care for cardiovascular disease, which remains the leading cause of death worldwide, have not been quantified. The study sought to assess COVID-19’s impact on global cardiovascular diagnostic procedural volumes and safety practices. The International Atomic Energy Agency conducted a worldwide survey assessing alterations in cardiovascular procedure volumes and safety practices resulting from COVID-19. Noninvasive and invasive cardiac testing volumes were obtained from participating sites for March and April 2020 and compared with those from March 2019. Availability of personal protective equipment and pandemic-related testing practice changes were ascertained. Surveys were submitted from 909 inpatient and outpatient centers performing cardiac diagnostic procedures, in 108 countries. Procedure volumes decreased 42% from March 2019 to March 2020, and 64% from March 2019 to April 2020. Transthoracic echocardiography decreased by 59%, transesophageal echocardiography 76%, and stress tests 78%, which varied between stress modalities. Coronary angiography (invasive or computed tomography) decreased 55% (p < 0.001 for each procedure). In multivariable regression, significantly greater reduction in procedures occurred for centers in countries with lower gross domestic product. Location in a low-income and lower–middle-income country was associated with an additional 22% reduction in cardiac procedures and less availability of personal protective equipment and telehealth. COVID-19 was associated with a significant and abrupt reduction in cardiovascular diagnostic testing across the globe, especially affecting the world’s economically challenged. Further study of cardiovascular outcomes and COVID-19–related changes in care delivery is warranted.
登录
查看更多内容
影响因子：
5.4
作者：
Choi, Andrew D.;Abbara, Suhny;Blankstein, Ron
通讯作者：
Blankstein, Ron
影响因子：
39.3
作者：
Einstein AJ;Pascual TN;Mercuri M;Karthikeyan G;Vitola JV;Mahmarian JJ;Better N;Bouyoucef SE;Hee-Seung Bom H;Lele V;Magboo VP;Alexánderson E;Allam AH;Al-Mallah MH;Flotats A;Jerome S;Kaufmann PA;Luxenburg O;Shaw LJ;Underwood SR;Rehani MM;Kashyap R;Paez D;Dondi M;INCAPS Investigators Group
通讯作者：
INCAPS Investigators Group
影响因子：
2.4
作者：
Skali, Hicham;Murthy, Venkatesh L.;Thompson, Randall C.
通讯作者：
Thompson, Randall C.
影响因子：
39.3
作者：
Baldi, Enrico;Sechi, Giuseppe Maria;Savastano, Simone
通讯作者：
Savastano, Simone
影响因子：
24
作者：
Fuster, Valentin;Frazer, Jendayi;Dzau, Victor
通讯作者：
Dzau, Victor